KYLIE ELIZABETH HANDS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Women's Health WINSTON SALEM, NC NPI 1699062976

General Payments — all program years on this page

$808.67

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 30
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $518.94 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $518.9421

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $289.739
2024 $518.9421

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086365625 Bayer Healthcare Pharmaceuticals Inc. $87.72 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091285871 Evofem Biosciences, Inc. $21.64 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091285874 Evofem Biosciences, Inc. $14.50 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091285876 Evofem Biosciences, Inc. $18.80 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091285881 Evofem Biosciences, Inc. $19.24 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091285884 Evofem Biosciences, Inc. $21.36 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100253396 Novo Nordisk Inc $20.29 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100381261 Novo Nordisk Inc $20.59 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100470240 Novo Nordisk Inc $20.65 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139471150 Astellas Pharma US Inc $13.09 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139485718 Astellas Pharma US Inc $14.06 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139502787 Astellas Pharma US Inc $14.05 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139511447 Astellas Pharma US Inc $13.77 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139515955 Astellas Pharma US Inc $12.24 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139520849 Astellas Pharma US Inc $19.00 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139541942 Astellas Pharma US Inc $13.57 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139545647 Astellas Pharma US Inc $102.91 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150128374 SHIELD THERAPEUTICS INC $14.93 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150135619 SHIELD THERAPEUTICS INC $18.20 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150789669 CooperSurgical, Inc. $22.63 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154685227 MAYNE PHARMA COMMERCIAL LLC $15.70 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.